Searchable Alterations Database
Comparison populations are quoted as reported in the source literature (e.g. healthy controls, disease-matched patients).
| Marker / Test | Direction | Category | vs. Comparison | Clinical Context | Key Reference |
|---|
Molecular, metabolic, immunological, and autonomic alterations in myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) compared to healthy sedentary and active controls — including post-exertional malaise (PEM) phenotypes.
Biomarkers below are included only where peer-reviewed literature explicitly reports the marker's direction in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome patients relative to a named comparison population — not inferred.
Comparison populations are quoted as reported in the source literature (e.g. healthy controls, disease-matched patients).
| Marker / Test | Direction | Category | vs. Comparison | Clinical Context | Key Reference |
|---|